PLRX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 6.40%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $1,831,157.46

Pliant Therapeutics Insider Trading History Chart

Pliant Therapeutics Share Price & Price History

^$1.47

▼ -0.04 (-2.65%)

As of 03/28/2025 05:00 PM ET

Days: 30 | 90 | 365

Pliant Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/22/2025	Mike Ouimette	General Counsel	Sell	10,230	$10.99	$112,427.70	70,544
1/17/2025	Bernard Coulie	CEO	Sell	52,419	$11.20	$587,092.80	430,517
1/17/2025	Hans Hull	Insider	Sell	15,936	$11.20	$178,483.20	211,558
1/17/2025	Mike Ouimette	General Counsel	Sell	13,270	$11.20	$148,624.00	80,774
7/10/2024	Bernard Coulie	CEO	Sell	38,710	$11.56	$447,487.60	482,936
7/10/2024	Eric Lefebvre	Insider	Sell	12,319	$11.56	$142,407.64	213,052
7/10/2024	Keith Lamont Cummings	CFO	Sell	10,911	$11.56	$126,131.16	282,115
7/10/2024	Mike Ouimette	General Counsel	Sell	7,656	$11.56	$88,503.36	94,044
1/17/2024	Bernard Coulie	CEO	Sell	25,721	$17.23	$443,172.83	316,382
1/17/2024	Hans Hull	Insider	Sell	9,786	$17.23	$168,612.78	185,069
1/17/2024	Keith Lamont Cummings	CFO	Sell	9,781	$17.23	$168,526.63	194,605
1/17/2024	Mike Ouimette	General Counsel	Sell	5,197	$17.23	$89,544.31	55,246
8/3/2023	Hans Hull	Insider	Sell	13,069	$20.00	$261,380.00	206,114
7/20/2023	Mike Ouimette	General Counsel	Sell	4,755	$17.55	$83,450.25	60,443
7/17/2023	Bernard Coulie	CEO	Sell	70,150	$18.01	$1,263,401.50	342,103
7/17/2023	Eric Lefebvre	Insider	Sell	22,321	$18.01	$402,001.21	167,215
7/17/2023	Keith Lamont Cummings	CFO	Sell	19,771	$18.01	$356,075.71	203,999
7/17/2023	Mike Ouimette	General Counsel	Sell	12,778	$18.01	$230,131.78	65,198
4/3/2023	Mike Ouimette	General Counsel	Sell	2,877	$26.79	$77,074.83	50,789
3/30/2023	Bernard Coulie	CEO	Sell	35,339	$26.52	$937,190.28	274,753
3/30/2023	Eric Lefebvre	Insider	Sell	11,245	$26.52	$298,217.40	145,786
3/30/2023	Keith Lamont Cummings	CFO	Sell	9,960	$26.52	$264,139.20	148,470
3/30/2023	Mike Ouimette	General Counsel	Sell	4,874	$26.52	$129,258.48	53,666
2/3/2023	Bernard Coulie	CEO	Sell	15,000	$33.61	$504,150.00	240,112
1/31/2023	Bernard Coulie	CEO	Sell	15,000	$34.92	$523,800.00	240,112
1/26/2023	Bernard Coulie	CEO	Sell	15,000	$35.29	$529,350.00	240,112
1/24/2023	Bernard Coulie	CEO	Sell	15,000	$30.89	$463,350.00	93,812
1/23/2023	Eric Lefebvre	Insider	Sell	67,500	$34.48	$2,327,400.00	76,926
1/23/2023	Keith Lamont Cummings	CFO	Sell	30,000	$35.00	$1,050,000.00	84,424
1/23/2023	Mike Ouimette	General Counsel	Sell	20,000	$34.19	$683,800.00	5,947
1/9/2023	Bernard Coulie	CEO	Sell	5,000	$19.17	$95,850.00	93,812
1/6/2023	Bernard Coulie	CEO	Sell	15,000	$19.04	$285,600.00	93,812
1/3/2023	Bernard Coulie	CEO	Sell	15,000	$19.33	$289,950.00	93,812
12/22/2022	Mike Ouimette	General Counsel	Sell	2,928	$19.38	$56,744.64	5,947
12/20/2022	Bernard Coulie	CEO	Sell	34,212	$19.10	$653,449.20	93,812
12/20/2022	Eric Lefebvre	Insider	Sell	10,887	$19.10	$207,941.70	144,426
12/20/2022	Keith Lamont Cummings	CFO	Sell	9,643	$19.10	$184,181.30	80,424
12/20/2022	Mike Ouimette	General Counsel	Sell	4,719	$19.10	$90,132.90	8,875
10/25/2022	Eric Lefebvre	Insider	Sell	5,000	$25.05	$125,250.00	133,437
9/12/2022	Bernard Coulie	CEO	Sell	12,502	$22.54	$281,795.08	59,273
7/11/2022	Bernard Coulie	CEO	Sell	15,000	$22.50	$337,500.00	59,273
7/11/2022	Eric Lefebvre	Insider	Sell	3,000	$20.00	$60,000.00	138,436

See Full Table

SEC Filings (Institutional Ownership Changes) for Pliant Therapeutics (NASDAQ:PLRX)

97.30% of Pliant Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Pliant Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/25/2025	Polar Asset Management Partners Inc.	62,600	$0.82M	0.0%	-63.2%	0.103%
2/18/2025	Frazier Life Sciences Management L.P.	1,120,803	$14.76M	0.6%	N/A	1.842%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	139,574	$1.84M	0.0%	+18.3%	0.229%
2/17/2025	Woodline Partners LP	127,295	$1.68M	0.0%	+14.0%	0.209%
2/17/2025	Two Sigma Investments LP	97,078	$1.28M	0.0%	-28.2%	0.160%
2/17/2025	Two Sigma Advisers LP	135,700	$1.79M	0.0%	-14.0%	0.223%
2/17/2025	Redmile Group LLC	2,895,478	$38.13M	2.7%	-9.4%	4.758%
2/17/2025	Polar Asset Management Partners Inc.	62,600	$0.82M	0.0%	-63.2%	0.103%
2/17/2025	ProShare Advisors LLC	18,931	$0.25M	0.0%	+31.8%	0.031%
2/17/2025	Paradigm Biocapital Advisors LP	3,197,050	$42.11M	1.5%	+3.0%	5.254%
2/17/2025	Nuveen Asset Management LLC	206,947	$2.73M	0.0%	-38.3%	0.340%
2/17/2025	OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC	103,563	$1.36M	0.1%	+22.0%	0.170%
2/17/2025	Granahan Investment Management LLC	527,147	$6.94M	0.3%	-28.6%	0.866%
2/17/2025	Deutsche Bank AG	2,551,865	$33.61M	0.0%	+66.3%	4.194%
2/17/2025	Corton Capital Inc.	10,497	$0.14M	0.1%	N/A	0.017%
2/17/2025	Bank of America Corp DE	120,977	$1.59M	0.0%	-80.7%	0.199%
2/17/2025	BNP Paribas Financial Markets	7,512	$99K	0.0%	N/A	0.012%
2/14/2025	First Light Asset Management LLC	1,681,110	$22.14M	2.1%	-34.7%	2.763%
2/14/2025	Northern Trust Corp	555,600	$7.32M	0.0%	+10.7%	0.913%
2/14/2025	Aquatic Capital Management LLC	5,596	$74K	0.0%	+1,299.0%	0.009%
2/14/2025	Blue Owl Capital Holdings LP	2,769,199	$36.47M	8.6%	-7.8%	4.551%
2/14/2025	Adage Capital Partners GP L.L.C.	649,660	$8.56M	0.0%	N/A	1.068%
2/14/2025	Price T Rowe Associates Inc. MD	4,634,486	$61.04M	0.0%	-4.1%	7.616%
2/14/2025	Silverarc Capital Management LLC	1,315,601	$17.33M	3.8%	N/A	2.162%
2/14/2025	Rock Springs Capital Management LP	404,796	$5.33M	0.2%	+5.1%	0.665%
2/14/2025	MetLife Investment Management LLC	36,788	$0.48M	0.0%	+11.9%	0.060%
2/14/2025	Dimensional Fund Advisors LP	547,297	$7.21M	0.0%	+20.0%	0.899%
2/13/2025	Marshall Wace LLP	53,880	$0.71M	0.0%	N/A	0.089%
2/13/2025	Jump Financial LLC	19,402	$0.26M	0.0%	N/A	0.032%
2/13/2025	Barclays PLC	101,823	$1.34M	0.0%	-75.8%	0.167%
2/13/2025	Fernwood Investment Management LLC	425,424	$5.60M	1.9%	-17.1%	0.699%
2/13/2025	Renaissance Technologies LLC	27,800	$0.37M	0.0%	-72.5%	0.046%
2/13/2025	Legal & General Group Plc	52,961	$0.70M	0.0%	+21.5%	0.087%
2/13/2025	ADAR1 Capital Management LLC	134,798	$1.78M	0.4%	-45.2%	0.222%
2/13/2025	Rhenman & Partners Asset Management AB	116,250	$1.53M	0.2%	-3.3%	0.191%
2/13/2025	Wells Fargo & Company MN	85,880	$1.13M	0.0%	-7.9%	0.141%
2/12/2025	ExodusPoint Capital Management LP	93,804	$1.24M	0.0%	-11.1%	0.154%
2/12/2025	Trexquant Investment LP	62,477	$0.82M	0.0%	-28.1%	0.103%
2/12/2025	Franklin Resources Inc.	1,045,577	$13.77M	0.0%	+0.5%	1.718%
2/12/2025	Pictet Asset Management Holding SA	1,266,030	$16.67M	0.0%	-1.1%	2.081%
2/12/2025	JPMorgan Chase & Co.	197,251	$2.60M	0.0%	+300.8%	0.324%
2/11/2025	Vanguard Group Inc.	3,228,755	$42.52M	0.0%	-8.4%	5.306%
2/11/2025	KLP Kapitalforvaltning AS	8,200	$0.11M	0.0%	N/A	0.013%
2/11/2025	American Century Companies Inc.	100,849	$1.33M	0.0%	+10.9%	0.166%
2/10/2025	Swiss National Bank	95,700	$1.26M	0.0%	+1.6%	0.157%
2/7/2025	AlphaQuest LLC	6,681	$88K	0.0%	-73.9%	0.011%
2/7/2025	Candriam S.C.A.	900,104	$11.85M	0.1%	+8.0%	1.479%
2/6/2025	Atria Investments Inc	11,821	$0.16M	0.0%	+18.1%	0.019%
2/6/2025	Charles Schwab Investment Management Inc.	459,384	$6.05M	0.0%	+0.6%	0.755%
1/31/2025	Rice Hall James & Associates LLC	160,522	$2.11M	0.1%	+2.1%	0.264%
1/31/2025	HighMark Wealth Management LLC	75,000	$0.99M	0.6%	+11.1%	0.123%
1/30/2025	Rhumbline Advisers	92,580	$1.22M	0.0%	-2.2%	0.152%
1/24/2025	China Universal Asset Management Co. Ltd.	12,903	$0.17M	0.0%	+10.3%	0.021%
1/23/2025	R Squared Ltd	2,490	$33K	0.0%	N/A	0.004%
1/17/2025	SG Americas Securities LLC	30,729	$0.41M	0.0%	+27.2%	0.050%
1/15/2025	Hennion & Walsh Asset Management Inc.	108,608	$1.43M	0.1%	+18.1%	0.178%
1/10/2025	Harbor Capital Advisors Inc.	95,801	$1.26M	0.1%	+4.2%	0.157%
12/13/2024	Exome Asset Management LLC	149,600	$1.68M	1.1%	+20.6%	0.246%
11/27/2024	Franklin Resources Inc.	1,039,904	$11.66M	0.0%	+1.5%	1.709%
11/16/2024	Geode Capital Management LLC	1,318,308	$14.78M	0.0%	+2.4%	2.166%
11/15/2024	Y Intercept Hong Kong Ltd	30,471	$0.34M	0.0%	N/A	0.050%
11/15/2024	Sphera Funds Management LTD.	297,362	$3.33M	0.5%	+15.0%	0.489%
11/15/2024	State Street Corp	1,402,730	$15.73M	0.0%	+1.9%	2.305%
11/15/2024	Redmile Group LLC	3,197,491	$35.84M	2.1%	-0.4%	5.254%
11/15/2024	Polar Asset Management Partners Inc.	170,200	$1.91M	0.0%	+265.2%	0.280%
11/15/2024	Checkpoint Capital L.P.	380,000	$4.26M	2.1%	+63.7%	0.624%
11/13/2024	Great Point Partners LLC	1,910,121	$21.41M	6.3%	-27.6%	3.139%
11/13/2024	FMR LLC	3,899,481	$43.71M	0.0%	-0.3%	6.408%
11/13/2024	The Manufacturers Life Insurance Company	75,268	$0.84M	0.0%	-9.8%	0.124%
11/12/2024	Algert Global LLC	106,562	$1.20M	0.0%	+52.6%	0.175%
11/12/2024	Charles Schwab Investment Management Inc.	456,663	$5.12M	0.0%	+4.4%	0.751%
11/9/2024	Intech Investment Management LLC	12,913	$0.15M	0.0%	N/A	0.021%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	34,611	$0.39M	0.0%	N/A	0.057%
11/7/2024	Quest Partners LLC	25,571	$0.29M	0.0%	-20.5%	0.042%
11/1/2024	Atria Investments Inc	10,009	$0.11M	0.0%	N/A	0.016%
10/29/2024	Fernwood Investment Management LLC	513,136	$5.75M	1.9%	+3.4%	0.844%
10/29/2024	Harbor Capital Advisors Inc.	91,979	$1.03M	0.0%	+233.8%	0.151%
10/28/2024	Rice Hall James & Associates LLC	157,217	$1.76M	0.1%	+23.2%	0.259%
10/25/2024	China Universal Asset Management Co. Ltd.	11,694	$0.13M	0.0%	+65.0%	0.019%
10/23/2024	Hennion & Walsh Asset Management Inc.	91,974	$1.03M	0.0%	+34.7%	0.151%
10/3/2024	SG Americas Securities LLC	24,150	$0.27M	0.0%	-47.4%	0.040%
8/16/2024	Algert Global LLC	69,842	$0.75M	0.0%	+312.5%	0.115%
8/15/2024	The Manufacturers Life Insurance Company	83,483	$0.90M	0.0%	+1.4%	0.137%
8/15/2024	Deerfield Management Company L.P. Series C	11,678	$0.13M	0.0%	N/A	0.019%
8/14/2024	Squarepoint Ops LLC	80,475	$0.87M	0.0%	N/A	0.132%
8/14/2024	First Light Asset Management LLC	3,401,213	$36.56M	3.2%	-3.8%	5.594%
8/14/2024	Great Point Partners LLC	2,636,864	$28.35M	5.4%	+42.4%	4.337%
8/14/2024	ProShare Advisors LLC	11,379	$0.12M	0.0%	-21.5%	0.019%
8/13/2024	Ensign Peak Advisors Inc	35,368	$0.38M	0.0%	+39.1%	0.059%
8/9/2024	Renaissance Technologies LLC	253,369	$2.72M	0.0%	+233.8%	0.420%
8/9/2024	Dimensional Fund Advisors LP	305,322	$3.28M	0.0%	+1.7%	0.506%
8/8/2024	American Century Companies Inc.	74,113	$0.80M	0.0%	+18.1%	0.123%
8/8/2024	Rice Hall James & Associates LLC	127,634	$1.37M	0.1%	N/A	0.212%
8/6/2024	Quest Partners LLC	32,175	$0.35M	0.0%	+75.8%	0.053%
8/6/2024	Candriam S.C.A.	833,216	$8.96M	0.1%	+52.0%	1.381%
8/1/2024	Rhumbline Advisers	96,488	$1.04M	0.0%	+17.9%	0.160%
7/29/2024	HighMark Wealth Management LLC	67,500	$0.73M	0.4%	+58.8%	0.112%
7/26/2024	Summit Securities Group LLC	5,532	$59K	0.0%	N/A	0.009%
7/26/2024	Bank of New York Mellon Corp	228,693	$2.46M	0.0%	+14.9%	0.379%
7/20/2024	Hennion & Walsh Asset Management Inc.	68,289	$0.73M	0.0%	N/A	0.113%

Data available starting January 2016

See Full Table

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. The company's lead candidate is bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which is in phase 2b trials for idiopathic pulmonary fibrosis and in phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins avß8 and avß1 for the treatment of solid tumors; and PLN-101325 for treatment of muscular dystrophies. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.

Today's Range

Now: $1.47

$1.46

$1.56

50 Day Range

MA: $4.82

$1.35

$12.55

52 Week Range

Now: $1.47

$1.26

$16.52

Volume

819,488 shs

Average Volume

1,001,653 shs

Market Capitalization

$90.02 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.18

Who are the company insiders with the largest holdings of Pliant Therapeutics?: Pliant Therapeutics' top insider investors include:
Bernard Coulie (CEO)
Keith Lamont Cummings (CFO)
Eric Lefebvre (Insider)
Hans Hull (Insider)
Mike Ouimette (General Counsel)
Learn More about top insider investors at Pliant Therapeutics.
Who are the major institutional investors of Pliant Therapeutics?: Pliant Therapeutics' top institutional investors include:
Price T Rowe Associates Inc. MD — 7.62%
Vanguard Group Inc. — 5.31%
Paradigm Biocapital Advisors LP — 5.25%
Redmile Group LLC — 4.76%
Blue Owl Capital Holdings LP — 4.55%
Deutsche Bank AG — 4.19%
Learn More about top institutional investors of Pliant Therapeutics stock.
Which major investors are selling Pliant Therapeutics stock?: During the previous quarter, PLRX stock was sold by these institutional investors:
First Light Asset Management LLC
Bank of America Corp DE
Barclays PLC
Redmile Group LLC
Vanguard Group Inc.
Blue Owl Capital Holdings LP
Granahan Investment Management LLC
Price T Rowe Associates Inc. MD
During the previous year, company insiders that have sold Pliant Therapeutics company stock include:
Bernard Coulie (CEO)
Keith Lamont Cummings (CFO)
Eric Lefebvre (Insider)
Hans Hull (Insider)
Mike Ouimette (General Counsel)
Learn More investors selling Pliant Therapeutics stock.
Which major investors are buying Pliant Therapeutics stock?: In the previous quarter, PLRX stock was bought by institutional investors including:
Silverarc Capital Management LLC
Frazier Life Sciences Management L.P.
Deutsche Bank AG
Adage Capital Partners GP L.L.C.
Caption Management LLC
JPMorgan Chase & Co.
Paradigm Biocapital Advisors LP
Dimensional Fund Advisors LP